Colleen Delaney

Colleen Delaney

Company: Deverra Therapeutics

Job title: Scientific Founder, Chief Scientific Officer and Executive VP of R&D


Panel Discussion: Leveraging the Experience of Cord Blood Banking in Development of Cellular Therapies 9:30 am

Along with gaining insights into how to tap into the expertise of cord blood banks and access therapy-matched cord blood units (CBUs), you’ll get a better understanding of: Comprehensive benefits of cord blood as an allogeneic cell source for cellular therapy Characteristics and attributes of the existing cord blood inventory Importance of managing logistics for…Read more

day: Day Two

Infusion of an Allogeneic Non-Engrafting Cell Therapy to Enhance Initial Remission Rates in Upfront AML Treatment 9:00 am

Description of an ex vivo expanded allogeneic stem/progenitor cell product generated from pooled donor cord blood Results from a phase 2 global randomized controlled trial using this product in patients with newly diagnosed AMLRead more

day: Day Two

Industry Leader’s Fireside Chat: Developing a Road Map From the Donor to the Final Product 8:15 am

A panel discussion from the industry leaders of the field to set the scene on the importance of effective donor selection. Ask your questions live to understand the expert’s thoughts on key topics including: Exploring demographics: to what extent do sex, age and health status play a role in potency? Creating the ultimate donor pool…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.